INTELLIGENT BIO SOLUTIONS INC. (INBS) Overview
- 1 Jan 2026: Period ending 31 Mar 2026; Estimate (m); Actual -1.80; Beat / miss (m).
- 1 Oct 2025: Period ending 31 Dec 2025; Estimate (m); Actual -2.82; Beat / miss (m).
- 1 Jul 2025: Period ending 30 Sept 2025; Estimate (m); Actual -0.35; Beat / miss (m).
- 1 Jan 2025: Period ending 31 Mar 2025; Estimate (m); Actual -4.41; Beat / miss (m).
Stock Price Chart
View more →Blue: Split-adjusted close · Orange: Cumulative dividend-reinvested close
Logarithmic scale. Both lines share the same starting value for the selected range.
- Last close
- $1.63
- Previous close
- $1.65
- Change
- -$0.02
- Change (%)
- -1.21%
- Close date
- 2026-09-29
- Previous close date
- 2026-09-28
- Open
- (m)
- Day high
- (m)
- Day low
- (m)
- Last session volume
- (m)
- Last session value
- (m)
- Currency
- USD
- Price basis
- split-adjusted
- Volume basis
- (m)
Performance
View more →Cumulative total returns · 2026-09-29
YTD
- INBS
- -82.90%
- S&P 500
- (m)
1 year
- INBS
- -85.70%
- S&P 500
- (m)
3 years
- INBS
- -98.68%
- S&P 500
- (m)
5 years
- INBS
- -99.97%
- S&P 500
- (m)
Earnings trends
View more →Earnings per share
USD / share · As filed
31 Mar 2026 ○ Estimate (m) ● Actual -1.80
Comparison details
| Period start | Period ending | Estimate | Actual | Beat / miss | Report date |
|---|---|---|---|---|---|
| 1 Jan 2026 | 31 Mar 2026 | (m) | -1.80 | (m) | (m) |
| 1 Oct 2025 | 31 Dec 2025 | (m) | -2.82 | (m) | (m) |
| 1 Jul 2025 | 30 Sept 2025 | (m) | -0.35 | (m) | (m) |
| 1 Jan 2025 | 31 Mar 2025 | (m) | -4.41 | (m) | (m) |
| 1 Oct 2024 | 31 Dec 2024 | (m) | -4.96 | (m) | (m) |
30 Jun 2026 ○ Estimate (m) ● Actual -8.44
Comparison details
| Period start | Period ending | Estimate | Actual | Beat / miss | Report date |
|---|---|---|---|---|---|
| 1 Jul 2025 | 30 Jun 2026 | (m) | -8.44 | (m) | (m) |
| 1 Jul 2024 | 30 Jun 2025 | (m) | -20.04 | (m) | (m) |
| 1 Jul 2023 | 30 Jun 2024 | (m) | -6.38 | (m) | (m) |
| 1 Jul 2022 | 30 Jun 2023 | (m) | -127.00 | (m) | (m) |
| 1 Jul 2021 | 30 Jun 2022 | (m) | -11.33 | (m) | (m) |
(m)
Revenue vs. Earnings
USD
30 Jun 2026 ■ Revenue 1.15M* ■ Earnings -3.91M* — Profit margin -341.04%*
30 Jun 2026 ■ Revenue 4.22M ■ Earnings -12.43M — Profit margin -294.91%
Analyst insights
View more →| Ratings | Buy | Hold | Sell | Other ratings | Last Close | Average Target | Upside | High Target | Low Target |
|---|---|---|---|---|---|---|---|---|---|
| (m) | (m) | (m) | (m) | (m) | $1.63 | (m) | (m) | (m) | (m) |
Recent news
View more →(m)
YouTube videos mentioning INBS
View more →(m)
Statistics
View more →Retained observations as of 2026-11-12; financial period ending 30 Jun 2026.
- Forward P/E
- (m)
- PEG ratio · 5-year expected
- (m)
- Shares held by insiders
- (m)
- Insider transactions · change (%)
- (m)
- Shares held by institutions
- (m)
- Institutional transactions · change (%)
- (m)
- Diluted EPS · 12 month
- (m)
- EPS estimate · next quarter
- (m)
- EPS estimate · next year
- (m)
- EPS growth · current annual estimate
- (m)
- EPS growth · next annual estimate
- (m)
- EPS growth · next 5 years expected
- (m)
- EPS growth · past 3 years annualized
- (m)
- EPS growth · past 5 years annualized
- (m)
- EPS change · 12 months vs prior year
- (m)
- EPS change · latest quarter vs previous quarter
- (m)
- Latest earnings report date
- (m)
- EPS surprise · latest reported quarter
- (m)
- Net income · 12 month
- $-12.43M
- Operating margin · 12 months
- -299.11%
- Gross margin · 12 months
- 48.63%
- Profit margin
- -294.91%
- Return on assets · 12 month
- -123.13%
- Index membership
- (m)
- Employees
- (m)
- IPO date
- (m)
- Options available
- (m)
- Shortable
- (m)
- Analyst recommendation
- (m)
- Analyst target price
- (m)
- Price volatility · week
- (m)
- Price volatility · month
- (m)
- Average true range · 14 sessions
- (m)
- Relative strength index · 14 sessions
- (m)
- Relative volume
- (m)
- Average daily volume
- 306.20K
- Latest session volume
- (m)
- Last session value
- (m)
- 30 days ago session value
- (m)
- 1 year ago session value
- (m)
- Number of trades
- (m)
- Total return · week
- -9.44%*
- Total return · month
- -30.93%*
- Total return · quarter
- -26.58%*
- Total return · half year
- -49.38%*
- Total return · year to date
- -82.90%*
- Total return · 1 year
- -85.70%*
- Total return · 3 years
- -98.68%*
- Total return · 5 years
- -99.97%*
- Market cap
- (m)
- Book value per share · latest quarter
- (m)
- Price / cash · latest quarter
- (m)
- Enterprise value
- (m)
- Enterprise value / revenue
- (m)
- Enterprise value / EBITDA
- (m)
- Dividend · 12 months per share
- (m)
- Dividend ex-date
- (m)
- Next dividend ex-date
- (m)
- Next dividend amount per share
- (m)
- Dividend growth · 3 years annualized
- (m)
- Dividend growth · 5 years annualized
- (m)
- Revenue · 12 month
- $4.22M
- Revenue growth · past 3 years annualized
- (m)
- Revenue growth · past 5 years annualized
- (m)
- Revenue change · 12 months vs prior year
- (m)
- Revenue change · latest quarter vs previous quarter
- (m)
- Revenue surprise · latest reported quarter
- (m)
- Operating cash flow · 12 months
- $-11.93M
- Free cash flow · 12 months (USD)
- $-12.05M
- Levered free cash flow · 12 month
- (m)
- Debt / equity · latest quarter
- (m)
- Long-term debt / equity · latest quarter
- (m)
- Payables · latest quarter (USD)
- $712.45K
- Return on equity · 12 month
- (m)
- Return on invested capital · 12 months
- (m)
- Previous close
- (m)
- Latest closing price
- (m)
- Latest session change (%)
- (m)
- 52-week high
- (m)
- 52-week low
- (m)
- Price vs 20-session moving average
- (m)
- Price vs 50-session moving average
- (m)
- Price vs 200-session moving average
- (m)
- Float shares
- (m)
- Short float (%)
- (m)
- Short ratio (days to cover)
- (m)
- Short interest (shares)
- (m)
Five-year projected P/E and P/S repeat the preceding five-year EPS and revenue CAGR, holding current price and market cap constant. Hover a calculated row for its formula. Net assets = assets − debt − payables − deferred revenue − obligations due within 1 year − obligations due after 1 year.
Holders breakdown
View more →| Breakdown | Ownership |
|---|---|
| (m) | Shares held by all insiders |
| (m) | Shares held by institutions |
| (m) | Float held by institutions |
| (m) | Institutions holding shares |
Other holders
(m)
Insider holders
(m)
Top institutional holders
(m)
Top mutual fund holders
(m)
INTELLIGENT BIO SOLUTIONS INC. Overview
View more →(m)
(m)
- SEC CIK
- 1725430
- Industry (SIC)
- 3841 Surgical & Medical Instruments & Apparatus
- Country of operation
- United States
- Business address
- 135 W 41ST ST,, FLOOR 5, NEW YORK, New York, 10036, United States
- Fiscal year end
- 0630
- Phone
- 646-790-5756
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |